Scientific work

Uzm. Dr. Şaban Seçmeler

41 publications. The source of the information is stated next to each publication.

Back to profile

  1. Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15725-9 PMID 41691201 Open-access full textSource: OpenAlex

  2. AI-augmented pharmacovigilance for cardio-oncology: FDR- controlled disproportionality and anomaly detection of antineoplastic-associated cardiac events in FAERS (2015 Q1–2025 Q4)

    Research Square, 2026

    DOI 10.21203/rs.3.rs-8961206/v1 Open-access full textSource: OpenAlex

  3. Radiation-Induced Pleomorphic Dermal Sarcoma of the Chest Wall 25 Years After Breast Cancer Radiotherapy: A Case Report and Literature Review

    Cureus, 2026

    DOI 10.7759/cureus.112878 PMID 42605482 Open-access full textSource: OpenAlex

  4. Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-29276-9 PMID 41315659 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  5. Bevacizumab Efficacy and Tolerability in Patients with Metastatic Platinum-Sensitive Ovarian Cancer Beyond Progression

    Cancer Management and Research, 2025

    DOI 10.2147/cmar.s531276 PMID 40861079 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  6. Detecting subclinical cardiotoxicity during immune checkpoint inhibitor therapy: a combined GLS and ECG repolarization analysis.

    Frontiers in oncology, 2025

    DOI 10.3389/fonc.2025.1615209 PMID 40697379 1 citation (Europe PMC) Open-access full textSource: ORCID

  7. Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

    BMC Cancer, 2024

    DOI 10.1186/s12885-023-11783-5 PMID 38166764 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome

    Indian Journal of Cancer, 2024

    DOI 10.4103/ijc.ijc_1283_20 PMID 39960699 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380 Open-access full textSource: OpenAlex

  10. Evaluation of ixabepilone efficacy and tolerability in metastatic breast cancer

    Medicine, 2024

    DOI 10.1097/md.0000000000040649 PMID 39809199 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  11. Tüm Vücut Hipertermi (Whole Body Hyperthermia)

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380.c14026 Source: OpenAlex

  12. Major and minor salivary gland cancers: A multicenter retrospective study

    Head & Neck, 2023

    DOI 10.1002/hed.27376 PMID 37084179 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  13. Are Syrian refugee breast cancer patients diagnosed at advanced stage and do they have treatment delays?

    Future Oncology, 2023

    DOI 10.2217/fon-2022-1093 PMID 37170860 2 citations (Europe PMC) Open-access full textSource: ORCID

  14. Pretreatment Modified Glasgow Prognostic Score for Predicting Prognosis and Survival in Elderly Patients with Gastric Cancer Treated with Perioperative FLOT

    Nutrients, 2023

    DOI 10.3390/nu15194156 PMID 37836440 9 citations (Europe PMC) Open-access full textSource: ORCID

  15. Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study

    Journal of Oncological Sciences, 2022

    DOI 10.37047/jos.2021-87391 Open-access full textSource: OpenAlex

  16. Are Syrian refugees breast cancer patients diagnosed at advanced stage? Is it a myth or reality?

    Research Square, 2022

    DOI 10.21203/rs.3.rs-2195867/v1 1 citation (Europe PMC) Open-access full textSource: ORCID

  17. The Relationship Between Spot Urinary Protein/Creatinine Ratio and HbA1C, Metabolic Parameters and Other Complications in Patients with Type 2 Diabetes

    Eurasian Journal of Medical Advances, 2022

    DOI 10.14744/ejma.2022.29392 1 citation (OpenAlex) Open-access full textSource: ORCID

  18. Efficacy of Trastuzumab and Potential Risk Factors on Survival in Patients with HER2-Positive Metastatic Gastric Cancer

    Future Oncology, 2021

    DOI 10.2217/fon-2021-0398 PMID 34323116 2 citations (Europe PMC) Source: OpenAlex

  19. Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study

    European Journal of Breast Health, 2021

    DOI 10.4274/ejbh.galenos.2020.6346 PMID 33870111 11 citations (Europe PMC) Open-access full textSource: OpenAlex

  20. The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy

    Cureus, 2021

    DOI 10.7759/cureus.14639 PMID 34046274 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  21. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study

    Tumori Journal, 2021

    DOI 10.1177/03008916211037739 PMID 34365852 5 citations (Europe PMC) Source: OpenAlex

  22. The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155219898504 PMID 31955700 3 citations (Europe PMC) Source: OpenAlex

  23. Does the Waiting Period for Genetic Tests Affect the Prognosis in Chemotherapy-Treated de novo Metastatic Non-Small Cell Lung Cancer Patients without a Driver Mutation?

    Oncology Research and Treatment, 2020

    DOI 10.1159/000511773 PMID 33242864 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  24. Adrenocortical Carcinoma:Single Center Experience

    Van Yüzüncü Yıl University Academic Data Management System, 2020

    Source: OpenAlex

  25. Prognostic Significance of Mean Platelet Volume on Local Advanced Non-Small Cell Lung Cancer Managed with Chemoradiotherapy

    Scientific Reports, 2019

    DOI 10.1038/s41598-019-40589-4 PMID 30850724 16 citations (Europe PMC) Open-access full textSource: OpenAlex

  26. The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy

    Current Problems in Cancer, 2019

    DOI 10.1016/j.currproblcancer.2019.05.007 PMID 31200961 12 citations (Europe PMC) Source: OpenAlex

  27. The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer

    Journal of Cancer Research and Therapeutics, 2019

    DOI 10.4103/jcrt.jcrt_326_18 PMID 33380674 12 citations (Europe PMC) Open-access full textSource: OpenAlex

  28. Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219865008 PMID 31366267 3 citations (Europe PMC) Source: OpenAlex

  29. The effects of fulvestrant treatment on hormone receptor-positive metastatic breast cancer

    The European Research Journal, 2019

    DOI 10.18621/eurj.470881 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  30. Non-urothelial Bladder Cancers: Single Center Experience

    European Archives of Medical Research, 2019

    DOI 10.4274/eamr.galenos.2019.21931 Open-access full textSource: OpenAlex

  31. Adrenocortical Carcinoma: Single Center Experience

    European Archives of Medical Research, 2019

    DOI 10.4274/eamr.25744 Open-access full textSource: OpenAlex

  32. Mide Kanserlerinde İmmünoterapiler: PD-1 ve PD-L1 İnhibitörleri

    Turkiye Klinikleri Medical Oncology - Special Topics, 2019

    Source: OpenAlex

  33. Factors Affecting Survival in Neuroendocrine Tumors: A 15-Year Single Center Experience

    Asian Pacific Journal of Cancer Prevention, 2018

    DOI 10.31557/apjcp.2018.19.12.3597 PMID 30583688 9 citations (Europe PMC) Open-access full textSource: OpenAlex

  34. Prognostic significance of primary tumor localization in stage II and III colon cancer

    World Journal of Gastrointestinal Oncology, 2018

    DOI 10.4251/wjgo.v10.i11.410 PMID 30487952 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  35. Fulvestrant efficacy in artificial menopausal hormone receptor positive and HER 2 negative metastatic breast cancer patients under 50 years old.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e13000 Source: OpenAlex

  36. Opere erken evre kolon kanserinde vücut kitle indeksinin nüks lokalizasyonu, hastalıksız sağkalım ve genel sağkalım etkisi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  37. Erken evre(1-3) kolon kanseri hastalarında tümör lokalizasyonunun hastalıksı sağkalım ve genel sağkalıma etkisi:tek merkez deneyimi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  38. Pleomorfik Sarkom tanılı hastada ifosfamid toksisitesi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  39. Opere iyi diferansiye Gastroenteropankreatik nöroendokrin tümörlerde Lenf nodu tutulumunun ve primer tümör lokalizasyonunun Klinik önemi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  40. Nüks Apendiks Adenokarsinoid Tümörü:Olgu Sunumu ve Literatür Güncellemesi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  41. Prognostic significance of high free T4 and low free T3 levels in non-thyroidal illness syndrome

    European Journal of Internal Medicine, 2018

    DOI 10.1016/j.ejim.2018.07.018 PMID 30029851 18 citations (Europe PMC) Source: ORCID